AJP - Regu AJP: Heart and Circulatory Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 282: R1618-R1627, 2002. First published February 28, 2002; doi:10.1152/ajpregu.00701.2001
0363-6119/02 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/6/R1618    most recent
00701.2001v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (13)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kopp, U. C.
Right arrow Articles by Smith, L. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kopp, U. C.
Right arrow Articles by Smith, L. A.
Vol. 282, Issue 6, R1618-R1627, June 2002

PGE2 increases release of substance P from renal sensory nerves by activating the cAMP-PKA transduction cascade

Ulla C. Kopp, Michael Z. Cicha, and Lori A. Smith

Department of Internal Medicine, Department of Veterans Affairs Medical Center, Iowa City 52246; and University of Iowa College of Medicine, Iowa City, Iowa 52242

Increasing renal pelvic pressure increases afferent renal nerve activity (ARNA) by a PGE2-mediated release of substance P (SP) from renal pelvic nerves. The role of cAMP activation in the PGE2-mediated release of SP was studied by examining the effects of the adenylyl cyclase (AC) activator forskolin and AC inhibitor dideoxyadenosine (DDA). Forskolin enhanced the bradykinin-mediated release of SP from an isolated rat renal pelvic wall preparation, from 7.3 ± 1.3 to 15.6 ± 3.0 pg/min. PGE2 at a subthreshold concentration for SP release mimicked the effects of forskolin. The EP2 receptor agonist butaprost, 15 µM, and PGE2, 0.14 µM, produced similar increases in SP release, from 5.8 ± 0.8 to 17.0 ± 2.3 pg/min and from 8.0 ± 1.3 to 21.6 ± 2.7 pg/min. DDA blocked the SP release produced by butaprost and PGE2. The PGE2-induced release of SP was also blocked by the PKA inhibitors PKI14-22 and H-89. Studies in anesthetized rats showed that renal pelvic administration of butaprost, 10 µM, and PGE2, 0.14 µM, resulted in similar ARNA responses, 1,520 ± 390 and 1,170 ± 270% · s (area under the curve of ARNA vs. time) that were blocked by DDA. Likewise, the ARNA response to increased renal pelvic pressure, 7,180 ± 710% · s, was blocked by DDA. In conclusion, PGE2 activates the cAMP-PKA pathway leading to a release of SP and activation of renal pelvic mechanosensory nerve fibers.

afferent renal nerves; EP2 receptors; calcitonin gene-related peptide; kidney; forskolin; adenylyl cyclase; protein kinase A; mechanosensory nerves


This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
U. C. Kopp, O. Grisk, M. Z. Cicha, L. A. Smith, A. Steinbach, T. Schluter, N. Mahler, and T. Hokfelt
Dietary sodium modulates the interaction between efferent renal sympathetic nerve activity and afferent renal nerve activity: role of endothelin
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2009; 297(2): R337 - R351.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
U. C. Kopp, S. Y. Jones, and G. F. DiBona
Afferent renal denervation impairs baroreflex control of efferent renal sympathetic nerve activity
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2008; 295(6): R1882 - R1890.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
U. C. Kopp, M. Z. Cicha, and M. A. Yorek
Impaired responsiveness of renal sensory nerves in streptozotocin-treated rats and obese Zucker diabetic fatty rats: role of angiotensin
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2008; 294(3): R858 - R866.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
C. Wang, Y. Gu, G.-W. Li, and L.-Y. M. Huang
A critical role of the cAMP sensor Epac in switching protein kinase signalling in prostaglandin E2-induced potentiation of P2X3 receptor currents in inflamed rats
J. Physiol., October 1, 2007; 584(1): 191 - 203.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
U. C. Kopp, M. Z. Cicha, L. A. Smith, J. Mulder, and T. Hokfelt
Renal sympathetic nerve activity modulates afferent renal nerve activity by PGE2-dependent activation of {alpha}1- and {alpha}2-adrenoceptors on renal sensory nerve fibers
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1561 - R1572.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
U. C. Kopp, M. Z. Cicha, and L. A. Smith
Differential effects of endothelin on activation of renal mechanosensory nerves: stimulatory in high-sodium diet and inhibitory in low-sodium diet
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2006; 291(5): R1545 - R1556.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
V. Perlik, Z. Li, S. Goorha, L. R. Ballou, and C. M. Blatteis
LPS-activated complement, not LPS per se, triggers the early release of PGE2 by Kupffer cells
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2005; 289(2): R332 - R339.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
U. C. Kopp, M. Z. Cicha, K. Nakamura, R. M. Nusing, L. A. Smith, and T. Hokfelt
Activation of EP4 receptors contributes to prostaglandin E2-mediated stimulation of renal sensory nerves
Am J Physiol Renal Physiol, December 1, 2004; 287(6): F1269 - F1282.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
U. C. Kopp and M. Z. Cicha
Impaired substance P release from renal sensory nerves in SHR involves a pertussis toxin-sensitive mechanism
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2004; 286(2): R326 - R333.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
H. Scholz
Prostaglandins
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2003; 285(3): R512 - R514.
[Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
U. C. Kopp, M. Z. Cicha, and L. A. Smith
Angiotensin blocks substance P release from renal sensory nerves by inhibiting PGE2-mediated activation of cAMP
Am J Physiol Renal Physiol, September 1, 2003; 285(3): F472 - F483.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
H. M. Stauss
Interaction of prostaglandins with the renin-angiotensin system
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2003; 284(4): R1010 - R1011.
[Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
U. C. Kopp, M. Z. Cicha, and L. A. Smith
Impaired responsiveness of renal mechanosensory nerves in heart failure: role of endogenous angiotensin
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2003; 284(1): R116 - R124.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online